Skip to main content
Loading

Current challenges for drug substance CDMOs in the Oligonucleotide space

30 Oct 2024
Manufacturing
Current challenges for drug substance CDMOs in the Oligonucleotide space
Industry Experts
Trishul Shah, Director Business Development, Head of Sales North America - PolyPeptide